Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes

Eva Ramírez de Arellano1,2, Jesús Saavedra-Lozano2,3, Pilar Villalón4

  • 1Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

Msphere
|March 5, 2024
PubMed

Insights

An increase in invasive Group A Streptococcus (GAS) infections in Spanish children was observed, with pneumonia being the most common severe presentation. Surveillance is crucial, as whole genome sequencing can aid in understanding and controlling GAS outbreaks.

Area of Science:

  • Microbiology
  • Epidemiology
  • Genomics

Background:

  • Group A Streptococcus (GAS) infections saw an unusual rise in Europe in late 2022.
  • Spain also reported an increase in both mild and severe GAS cases.
  • The reasons for this increase and the characteristics of the involved strains were unclear.

Purpose of the Study:

  • To characterize the clinical, microbiological, and molecular features of invasive GAS (iGAS) infections in Spanish children.
  • To compare iGAS strains with those causing mild infections.
  • To investigate the potential causes of increased iGAS incidence and severity.

Main Methods:

  • Prospective recruitment of pediatric patients with GAS infections in Spain (September 2022-March 2023).
  • Microbiological analysis including emm typing, antimicrobial susceptibility testing, and whole genome sequencing (cgMLST, resistome, virulome).
  • Clinical data collection for cases and controls.

Main Results:

  • Pneumonia was the most frequent iGAS syndrome (44.1%), often requiring pediatric intensive care.
  • emm1 and emm12 were the predominant emm types, with the M1_UK sublineage appearing in Spain.
  • The speA gene was associated with pneumonia, while the ssa superantigen was linked to milder cases; isolates remained largely susceptible to antimicrobials.

Conclusions:

  • The rise in iGAS incidence in Spain was not linked to increased antimicrobial resistance or a significant emm type shift.
  • Increased severity, particularly pneumonia, may have contributed to the observed rise in iGAS cases.
  • Enhanced surveillance and the use of whole genome sequencing are recommended for better understanding and control of iGAS.